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Alterations in the target proteins of fluoroquinolones, especially in GyrA and ParC,
are known to cause resistance. Here, we investigated environmental Escherichia
communities to explore the possible link between the abundance of mutations, and the
exposure to fluoroquinolones. Sediment samples were collected from a relatively pristine
lake, up and downstream from a sewage treatment plant, and from several industrially
polluted sites. The quinolone resistance-determining regions of gyrA and parC were
analyzed using amplicon sequencing of metagenomic DNA. Five non-synonymous
substitutions were present in all samples, and all of these mutations have been
previously linked to fluoroquinolone resistance in Escherichia coli. In GyrA, substitutions
S83L and D87N were on average detected at frequencies of 86 and 32%, respectively,
and 31% of all amplicons encoded both substitutions. In ParC, substitutions S80I,
E84G, and E84V were detected in 42, 0.9, and 6.0% of the amplicons, respectively,
and 6.5% encoded double substitutions. There was no significant correlation between
the level of fluoroquinolone pollution and the relative abundance of resistance mutations,
with the exception of the most polluted site, which showed the highest abundance of
said substitutions in both genes. Our results demonstrate that resistance mutations can
be common in environmental Escherichia, even in the absence of a fluoroquinolone
selective pressure.
Keywords: antimicrobial agents, mechanisms of resistance, antibiotics, microbial communities, next generation
sequencing
INTRODUCTION
Fluoroquinolones are a class of synthetic broad-spectrum antibiotics that target the type II
topoisomerases (DNA gyrase and topoisomerase IV) involved in the maintenance of DNA
topology. DNA gyrase and topoisomerase IV are both tetrameric enzymes composed of two X
and two Y subunits (X2Y2). DNA gyrase is encoded by the genes gyrA and gyrB, and topoisomerase
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IV is encoded by parC and parE. The enzymes are homologues,
and there is a considerable sequence similarity between gyrA and
parC, and between gyrB and parE. One of the main mechanisms
of ﬂuoroquinolone resistance is amino acid substitutions in
the DNA gyrase and topoisomerase IV proteins, in particular
in GyrA and ParC (Ruiz, 2003; Hopkins et al., 2005). Several
resistance mutations have been characterized in Escherichia coli,
and the majority of these are located in the quinolone resistance-
determining region (QRDR) deﬁned as codons 67–106 in gyrA
and 56–108 in parC (E. coli numbering). Certain single mutations
in gyrA are suﬃcient to generate high-level resistance to nalidixic
acid, a non-ﬂuorinated ﬁrst generation quinolone. Additional
mutations in gyrA or other type II topoisomerase genes are,
however, necessary for high-level resistance to later generations
of ﬂuoroquinolones, such as ciproﬂoxacin (Hopkins et al., 2005).
Indeed, a study of 58 ﬂuoroquinolone-resistant clinical E. coli
isolates from two hospitals in Houston, TX, USA, found that all
isolates had amino acid substitutions in GyrA and approximately
85% had additional substitutions in ParC (Morgan-Linnell
et al., 2009), conﬁrming chromosomal mutations as the main
mechanism of clinically relevant ﬂuoroquinolone resistance. The
frequency of resistant invasive E. coli infections in Europe in
2012 ranged from 9.7% in Iceland to 42.0% in Cyprus (ECDC,
2013). Surveillance outside of Europe is less systematic, but a
hospital in India reported that as many as 73% of uropathogenic
E. coli infections were resistant to ciproﬂoxacin (Mandal et al.,
2012).
Escherichia coli primarily propagate in the intestines of warm
blooded animals, but also, to a limited extent, in the environment
(Ishii and Sadowsky, 2008). Because ﬂuoroquinolones are strictly
synthetic antibiotics, it would be reasonable to assume that
resistance mutations are not as common in environmental
E. coli isolates as they are among clinical isolates. Accordingly,
screening of environmental bacteria from an isolated cave for
antibiotic resistance showed very few isolates that were resistant
to a high concentration of ciproﬂoxacin (MIC >20 mg/l),
whereas resistance to other classes of antibiotics were more
common (Bhullar et al., 2012). Similarly, a recent study
from our group found that only <1–6% of bacteria isolated
from lakes with no documented history of ﬂuoroquinolone
pollution, in Sweden and India, were ciproﬂoxacin-resistant
(MIC >2 mg/l) (Flach et al., 2015). A characterization of
the QRDR of gyrA from 20 environmental E. coli isolates
showed that there was considerable variability in the amino
acid sequence (Waters and Davies, 1997), and a study of 38
highly ciproﬂoxacin-resistant (MIC 6–128 mg/l) soil-dwelling
bacterial isolates of diﬀerent species showed that nine isolates
(24%) contained amino acid substitutions in this region (D’Costa
et al., 2006). This suggests that mutations in the QRDR can
be present in environmental bacteria even in the absence of
ﬂuoroquinolones. The methods used in previous studies have,
however, been low throughput, making the estimation of the
abundance of mutations unreliable. Previous studies have also
been dependent on the culturability of the bacteria, and often
focused on phenotypically ﬂuoroquinolone-resistant bacteria
(Adachi et al., 2013; Zurﬂuh et al., 2014). The characteristics
and relative abundance of resistance mutations in the QRDRs
in environmental bacterial communities, have, thus remained
unknown.
Recently, concerns have been raised about the risks of
resistance development due to antibiotic contamination of the
external environment (Gaze et al., 2013; Pruden et al., 2013;
Wellington et al., 2013). Antibiotics, including ﬂuoroquinolones,
can enter the environment through, for example, human
sewage and use in animal farming (Kümmerer, 2009). The
highest concentrations of ﬂuoroquinolones detected in the
environment are, however, the result of direct discharge
from manufacturing (Larsson et al., 2007; Fick et al., 2009;
Kristiansson et al., 2011). It is therefore important to assess
the risks of the development and spread of resistant bacteria
in contaminated environments. Furthermore, because the
discharge of antibiotics may be intermittent and diﬃcult to
detect, acquired resistance characteristics of environmental
bacteria may, given suﬃcient evaluation, serve as sentinels and
biomarkers for antibiotic exposure. The presence and abundance
of qnr-genes, a group of mobile ﬂuoroquinolone resistance
genes, in microbial communities have been shown previously
to correlate with ﬂuoroquinolone contamination of stream
sediments (Kristiansson et al., 2011). However, horizontally
transferred genes are not ubiquitous and may, therefore,
not be optimal as biomarkers. In contrast, chromosomal
resistance mutations can appear de novo and be enriched in a
population under suﬃcient antibiotic selective pressure. Hence,
we hypothesize that resistance mutations in gyrA and parC could
serve as biomarkers for ﬂuoroquinolone exposure in diﬀerent
environments.
The aim of the present study was to assess the abundance
of chromosomal ﬂuoroquinolone resistance mutations in
environmental Escherichia communities and to investigate the
potential link to ﬂuoroquinolone pollution. Using massively
parallel amplicon sequencing of metagenomic DNA, we
determined the full genetic resistance characteristics of the
QRDR of gyrA and parC in Escherichia communities without
any prior culturing of bacteria. The studied environments
included a range of selective pressures for ﬂuoroquinolone
resistance from a highly polluted Indian stream, samples taken
up and downstream from a Swedish sewage treatment plant,
and from a remote small Swedish lake under minimal human
impact. This allowed us to investigate a possible correlation
between ﬂuoroquinolone pollution and the abundance of
resistance mutations. Our analysis showed a high abundance of
ﬂuoroquinolone resistance mutations in both gyrA and parC in
all investigated environments, but, interestingly, we did not ﬁnd
any signiﬁcant correlation with the levels of ﬂuoroquinolones
detected.
MATERIALS AND METHODS
Sample Collection
Samples were taken from an Indian stream and a Swedish stream
both upstream (two in India, one in Sweden) and downstream
(three in India, one in Sweden) of wastewater treatment plants
(WWTPs) as described previously (Kristiansson et al., 2011).
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The Indian WWTP is situated in Patancheru near Hyderabad,
India, and at the time of sampling, it received industrial eﬄuent
from approximately 90 pharmaceutical industries. The Swedish
WWTP is located in Skövde and receives municipal wastewater,
but with no input from pharmaceutical industries. These seven
samples have previously been analyzed for the presence of mobile
antibiotic resistance genes using metagenomic sequencing
(Kristiansson et al., 2011), and qnr genes using qPCR (Rutgersson
et al., 2014). For this study, three additional sediment samples
were collected from an upland Swedish small lake, Valbergs
öga, situated far from habitation, roads and farmland and
with no apparent inﬂow of water (2012-07-25, GPS coordinates
57◦51′34.2′′N 12◦04′58.2′′E). Although few places on earth
could be referred to as completely pristine, very few people,
if any, are likely to walk near this small lake in a given year.
Thus, it represents an environment at the very low end in
terms of human impact. To determine the ﬂuoroquinolone
selective pressure at the samplings sites, the concentrations of
ciproﬂoxacin, diﬂoxacin, enoxacin, enroﬂoxacin, lomeﬂoxacin,
oﬂoxacin, peﬂoxacin, and norﬂoxacin were measured in all
samples using liquid chromatography coupled to an ion trap
mass spectrometer and electro spray interface (LC-ESI-IT-
MSMS) described previously by Kristiansson et al. (2011),
where the original chemical analysis data of all of the stream
sediment samples can be found. The Swedish lake samples
were analyzed at a diﬀerent time point using the same
method. Results were expressed per gram organic matter,
rather than per total weight as some samples contained a
large proportion of inorganic material (gravel). The detection
limit was 0.02 µg/g organic matter for each measured
substance.
DNA Extraction
The total DNA was extracted from the sediment samples
and ampliﬁed using uniform whole genome ampliﬁcation.
A PowerSoil
R©
DNA Isolation Kit (MO BIO Laboratories, Inc.,
Carlsbad, CA, USA) was used for the DNA extraction with
the following modiﬁcation to the manufacturer’s protocol:
to complete homogenization and cell lysis, the power bead
tubes with sediment and solution C1 were incubated at 70◦C
for 10 min with a brief vortex after 5 and 10 min. The
DNA concentration was measured using a NanoDrop (Thermo
Fisher Scientiﬁc Inc., Waltham, MA, USA), and the samples
were stored at −80◦C until the whole genome ampliﬁcation
of puriﬁed genomic DNA was performed. Uniform whole
genome ampliﬁcation was done using the REPLI-g mini kit
(QIAGEN, Hilden, Germany). The DNA (10 ng) was denatured
by adding a denaturation buﬀer and incubating for 3 min
at room temperature. The denaturation was interrupted by a
neutralization buﬀer and a master mix containing a reaction
buﬀer, and DNA polymerase was added. All buﬀers and enzyme
mixtures were made according to the protocol. The ampliﬁcation
reaction was performed by incubating the samples at 30◦C
for 16 h in a thermal cycler, after which the reaction was
stopped by heating the sample for 3 min at 65◦C. The DNA
concentration was measured using a NanoDrop, and the samples
were stored at −20◦C before the PCR ampliﬁcation of the target
genes.
PCR Amplification of gyrA and parC
The software Primer3 (Rozen and Skaletsky, 2000) was used
through the web interface Primer3Plus (Untergasser et al., 2007)
to design PCR primers targeting the regions of gyrA and parC
that include all resistance mutations reported by Ruiz (2003).
To avoid placing primers in variable regions, all annotated gyrA
and parC nucleotide sequences belonging to Escherichia were
downloaded from the Pathosystems Resource Integration Center
(PATRIC) (Gillespie et al., 2011) and each gene was aligned using
MUSLCE (Edgar, 2004). Because Shigella is indistinguishable
from Escherichia in the targeted gene regions, this genus was
also added to the multiple sequence alignment. All variable
positions were given as excluded regions in Primer3, and the
portions including all resistance mutations were given as the
target regions. The product size range was set as 250–350 base
pairs (bps) so that the amplicons would, to a large extent, be
completely covered by a single 454 sequence read. The top 10
suggested primers were tested experimentally to determine the
best primer pair, producing the largest amount of amplicons of
the expected length, for each gene. The selected primers, targeted
regions, and experimental design are shown in Table 1.
All of the samples were ampliﬁed using the selected
primer pair for each gene and the set-up described in
Table 1. The following was combined in sterile 0.2 ml tubes:
1xGotaq
R©Reaction buﬀer, 0.2 mM dNTP Mix, 0.4 µM forward
primer, 0.4 reverse primer, 1.25 µ GoTaq
R©
DNA polymerase
(Promega, Madison, WI, USA), 50 ng template, and water up
to 25 µl. The PCR ampliﬁcation used an initial denaturation
at 95◦C for 2 min, denaturation at 95◦C for 10 s, annealing
at 57◦C for 30 s, extension at 72◦C for 1 min, and a ﬁnal
extension for 7 min. Each reaction was run for 40 cycles to
maximize the amount of amplicon DNA. The PCR products were
separated using 1.5% agarose gel electrophoresis and visualized
with ethidium bromide. The DNA fragment of interest was
excised from the agarose gel and placed in a microcentrifuge tube,
and the GeneJETTM gel extraction kit (Fermentas International
Inc., Vilnius, Lithuania) was used according to the enclosed
protocol to obtain the DNA amplicons. The puriﬁed amplicons
were pooled to enable sequencing in a single run, and therefore,
TABLE 1 | Selected primers with target regions and experimental setup.
Gene Target region Product size Forward primer Reverse primer Annealing
temperature
gyrA 129–439 311 bp ggtacaccgtcgcgtacttt caacgaaatcgaccgtctct 57◦C
parC 20–306 287 bp gccttgcgctacatgaattt accatcaaccagcggataac 57◦C
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each sample contained amplicons of both gyrA and parC derived
from the same sample site. The amplicons were stored at −20◦C
before sequencing.
DNA Sequencing and Bioinformatics
Analyses
The samples were sent to GATC Biotech (Konstanz, Germany)
for multiplexed massively parallel pyrosequencing (Margulies
et al., 2005) using titanium chemistry on the GS FLX+ system.
The sequencing of the Swedish lake samples was performed
on a separate time point. The resulting sequence reads were
aligned to their respective reference sequence belonging to E. coli
K-12 MG1655 (RefSeq locus tags, gyrA: b2231; parC: b3019)
using GS Amplicon Variant Analyzer from 454 (v2.5p1). The
aligned reads were exported from the software as one FASTA
alignment ﬁle per gene and sample site. To limit the risk of
interpreting sequence variability between species as resistance
mutations, reads too dissimilar to the Escherichia and Shigella
sequences were discarded after matching all reads against all
sequences annotated with the gene symbol gyrA and parC,
respectively, in the Comprehensive Microbial Resource (CMR)
(Peterson et al., 2001) using BLASTn (Altschul et al., 1990). Only
reads with a hit against a gyrA or parC sequence from either
Escherichia or Shigella, and with an E-value lower than 1× 10−100
were retained in the subsequent analysis. To compensate for the
issue of homopolymers, which are common in 454 sequencing,
any positions in the multiple sequence alignments with insertions
in the reference sequence were removed, and any remaining
deletions in the reads were substituted with the reference
sequence base of that position. The resulting gapless reads were
translated using the EMBOSS tool Transeq (reading frame 1 for
gyrA and 2 for parC) (Rice et al., 2000). The relative abundance
of non-synonymous substitutions was recorded. The relative
abundance of a certain mutation was deﬁned as the percentage
of reads encoding that particular amino acid substitution. The
average relative abundance of mutations was deﬁned as the
percentage of reads encoding any amino acid substitution
averaged over all samples. The computations were done for
both individual substitutions, and pairs of substitutions occurring
within the same read. The correlation between ﬂuoroquinolone
pollution – measured as the total amount of ﬂuoroquinolones
detected (log-transformed) – and the abundance of resistance
mutations was measured using Pearson’s correlation coeﬃcient.
Nucleotide Sequence Accession Number
The raw sequence data have been submitted to the Short
Read Archive (SRA) under BioProject accession number
PRJNA239415.
RESULTS
The measurements of the ﬂuoroquinolone concentrations
present in the sediments conﬁrmed that the sampled
environments represented a range of diﬀerent ﬂuoroquinolone
selective pressures (see Supplementary Table S1). Ciproﬂoxacin,
enroﬂoxacin, and peﬂoxacin were detected at all Indian
sample sites, oﬂoxacin was detected only upstream from the
Indian WWTP, and lomeﬂoxacin and diﬂoxacin were detected
only at the Indian downstream sites. None of the analyzed
ﬂuoroquinolones were detected in any of the Swedish samples.
The highest level of ﬂuoroquinolones was detected in the Indian
downstream samples, while the upstream samples contained
moderately high levels, as reported previously (Kristiansson
et al., 2011).
A total of 35,417 reads aligned to the gyrA reference sequence
(1,453–6,339 reads per sample), and 51,933 reads aligned to
the parC reference sequence (537–15,469 reads per sample)
(Table 2). The ﬁltering of reads dissimilar to known Escherichia
and Shigella sequences retained on average 60% of the gyrA reads
(45–91% per sample) and 78% of the parC reads (72–95% per
sample), suggesting that the parC primer pair is more speciﬁc for
the targeted genera in the sampled environments compared to
the gyrA primers. For gyrA, a total of 21,295 reads were used in
the subsequent analysis (790–3,104 reads per sample), and 40,521
reads were used for parC (509–12,006 reads per sample).
Out of all the non-synonymous substitutions detected, the
variability in codon 83 and 87 in gyrA and in codon 80 in parC
was considerably higher than at any other codon (Figure 1).
TABLE 2 | Number of reads that aligned and that was retained after quality filtering.
Country Site Sample Aligned reads Filtered reads
GyrA ParC GyrA ParC
India Downstream 1 3,051 712 2,281 658
2 1,531 3,759 790 3,425
3 2,788 537 1,753 509
Upstream 1 3,409 766 3,104 658
2 3,057 1,919 1,838 1,664
Sweden Downstream 1,453 2,079 888 1,831
Upstream 4,425 2,926 2,773 2,112
Lake 1 4,672 15,469 2,438 12,006
2 4,692 12,446 2,609 9,039
3 6,339 11,320 2,821 8,619
Sum 35,417 51, 933 21,295 40,521
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FIGURE 1 | Detected average variability over the amplicon. The average relative abundance of non-synonymous substitutions in each codon of (A) the gyrA
and (B) the parC amplicons, averaged over all samples.
Three non-synonymous mutations in gyrA were detected in all
samples and they encode the following amino acid substitutions:
S83L, D87N, and D82G (see Supplementary Table S2a). The most
common substitution, S83L, was detected in a majority of reads
in all samples (61–97%), while D87N was less abundant (1–
62%). Almost all of the D87N substitutions (97%) occurred in
reads also encoding the S83L substitution. Although the D82G
substitution was detected in all samples, it was rare (≤1%), as
were other resistance mutations detected in only some of the
samples (0–2%). Three non-synonymous mutations in parC were
detected in all samples and they encode the following amino
acid substitutions: S80I, E84G, and E84V (see Supplementary
Table S2b). S80I was the most common substitution encoded
by the parC amplicons, and was detected in 0.4–63% of the
reads in each sample. The mutations in codon 84 were far less
common, but 98% of all reads carrying substitutions in codon
84 also carried mutations encoding the S80I substitution. Other
resistance mutations in parC, which were detected in only some
of the samples, were rare (0–7%).
The diﬀerences in terms of non-synonymous mutations
between the environments were small, and there was no
obvious link between the abundance of these mutations and
the ﬂuoroquinolone selective pressure for either gyrA or parC
(Figure 2, also see Supplementary Figures S1 and S2). Pearson’s
correlation coeﬃcient between the log-transformed detected
amounts of total ﬂuoroquinolones (samples with no detected
ﬂuoroquinolones were set to the detection limit 0.02µg/g organic
matter) and the abundance of the most commonly detected
substitutions were as follows: S83L, −0.058 (p = 0.87); D87N,
0.098 (p = 0.79); and S83L+D87N in GyrA, 0.088 (p = 0.81);
S80I, −0.25 (p = 0.49); E84G, 0.54 (p = 0.10); E84V, 0.28
(p= 0.42); and S08I+E84G/V in ParC, 0.34 (p = 0.26). However,
the sample taken downstream from and closest to the discharge
site of the Indian WWTP showed the highest abundance of all
said substitutions (Figure 2, also see Supplementary Figures S1a
and S2a).
DISCUSSION
In this study, we measured the relative abundance of
chromosomal ﬂuoroquinolone resistance mutations in
Escherichia communities residing in both uncontaminated
and severely ﬂuoroquinolone polluted aquatic environments.
We detected a high abundance of resistance mutations in
the chromosomal target genes of ﬂuoroquinolones, gyrA and
parC, in all sampled environments, including environments
with no ﬂuoroquinolone pollution or known history thereof.
Interestingly, we found no association between the measured
concentrations of ﬂuoroquinolones at the samples sites and
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FIGURE 2 | The link between fluoroquinolone pollution and mutations in the quinolone resistance determining region. Correlation between the measured
total fluoroquinolone pollution (µg/g organic matter) and the relative abundance of the most commonly detected non-synonymous substitutions in (A) gyrA and
(B) parC. Samples with no detected fluoroquinolones are indicated in the figure as 0.2 µg/g (i.e., the detection limit).
the abundance of resistance mutations, except for the most
polluted site, which showed the highest abundance of the most
commonly detected mutations. This suggests that chromosomal
mutations conferring ﬂuoroquinolone resistance only could be
considered a potential biomarker for detecting very extensive
ﬂuoroquinolone pollution. Additionally, the high abundance of
mutations previously linked to ﬂuoroquinolone resistance and
the low abundance of other mutations indicate that there could
be selective advantages to carry the resistance mutations in the
sampled environments, even in the absence of ﬂuoroquinolone
selective pressure. Note that the levels of ﬂuoroquinolones
detected in the sediment cannot be directly compared to those
of water solutions, as some ﬂuoroquinolones are known to
sorb to soil particles (Girardi et al., 2011). The exact amount of
bioavailable antibiotics is, therefore, unknown, but likely lower
than the detected levels.
To our best knowledge, the lowest reported minimal selective
concentration for any antibiotic and resistance mutation is
0.1 µg/l for ciproﬂoxacin and the S83L substitution in GyrA
(Gullberg et al., 2011). This concentration is just above the
ones found in treated Swedish sewage eﬄuents (Lindberg
et al., 2005; Fick et al., 2011). However, the concentration
was determined through competition experiments in a
lab setting, and therefore, comparisons to environmental
conditions should be made with some caution. Although
no ﬂuoroquinolones were detected downstream from the
Swedish sewage treatment plant in this study, bacteria leaving
the plant could theoretically have encountered selective
concentrations inside the treatment plant. In the investigated
Swedish lake, however, there are no plausible sources for
ﬂuoroquinolone exposure, indicating that the mutations
found here are not present because of a ﬂuoroquinolone
selection pressure. Furthermore, since there is little diﬀerence
in mutation abundance between the severely polluted sites
and the remote Swedish lake, the data implies that the
mutation abundance is not connected to ﬂuoroquinolone
selection pressure, but is largely determined by other, unknown
factors.
In gyrA, mutations encoding the amino acid substitutions
S83L and D87N were detected in all samples, with almost all
of the D87N substitutions occurring in reads also encoding
the S83L substitution. Both substitutions have been associated
with ﬂuoroquinolone resistance for E. coli and confer higher
levels of resistance than any other substitutions in the QRDR
(Yoshida et al., 1991). In ﬂuoroquinolone-resistant clinical E. coli
isolates, S83 is the most frequently altered amino acid, and,
moreover, S83L is the most common substitution (Hopkins
et al., 2005). A single substitution at position 83 confers higher
resistance than at position 87, but additional mutations in gyrA
or other genes are necessary for the development of high-
level ﬂuoroquinolone resistance. The S83L substitution alone,
however, confers the same level of resistance to ciproﬂoxacin
for E. coli as the combination of S83L and D87N (increased
MIC of ciproﬂoxacin from 0.016 to 0.38 mg/l), while the D87N
substitution alone confers slightly lower resistance (ciproﬂoxacin
MIC = 0.25 mg/l) (Marcusson et al., 2009; Machuca et al., 2014).
In parC, mutations causing the substitutions S80I, E84G, and
E84V were detected in all samples, and these three substitutions
have been previously linked to ﬂuoroquinolone resistance in
E. coli. In ﬂuoroquinolone-resistant clinical isolates, the most
commonly altered amino acid in ParC is S80 followed by E84,
and, speciﬁcally, S80I is the most common substitution (Hopkins
et al., 2005). Substitutions in ParC are often, if not always,
found together with substitutions in GyrA in ﬂuoroquinolone-
resistant isolates (Hopkins et al., 2005; Morgan-Linnell et al.,
2009), and substitutions of S80 or E84 alone do not aﬀect the
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susceptibility to ﬂuoroquinolones unless GyrA is also altered
(Bagel et al., 1999). Because of the method used in this study,
it is not possible to determine to what extent the detected
mutations in gyrA and parC occur in the same bacterium, but
it is worth mentioning that a combination of the substitutions
S83L and D87N in GyrA with S80I in ParC confers a very
high resistance to ciproﬂoxacin (ciproﬂoxacin MIC = 32 mg/l)
(Marcusson et al., 2009). To set the MICs into perspective, an
Enterobacteriaceae isolate is classiﬁed as ciproﬂoxacin-resistant
if its MIC is higher than 1 mg/l according to the EUCAST
clinical breakpoints (EUCAST, 2014). Isolates with a MIC lower
than 0.5 mg/l are classiﬁed as sensitive. It is important to note
that ﬂuoroquinolone resistance can be caused by a number
of diﬀerent genetic mechanisms and combinations thereof. To
extrapolate a level of resistance solely from mutations in the
target genes is associated with a high level of uncertainty,
therefore, the MICs given above are only included as a rough
reference.
The only sampling site that stood out in terms of high
abundance of resistance mutations was the site closest to
downstream of the discharge site of the Indian WWTP. Here,
we observed the highest abundance of the S83L and D87N
substitutions in GyrA, the S80I, E84G, and E84V substitutions
in ParC, and, consequently, also the highest abundance of the
paired substitutions in both proteins. This is indeed the sample
site with the highest total concentration of ﬂuoroquinolones,
which would be consistent with the hypothesis that there is a
selective advantage for resistance mutations in ﬂuoroquinolone-
polluted environments, but only at locations with very high
concentrations of ﬂuoroquinolones. However, some reads from
the most polluted site did not contain any mutations that
resulted in amino acid substitutions in either gyrA (1.2%)
or parC (30%), which suggests that some bacteria thriving
there may carry additional resistance factors protecting them.
Indeed, we have shown previously that mobile ﬂuoroquinolone-
resistance genes (qnr) are highly abundant in the stream
sediment (Rutgersson et al., 2014). The qnr genes provide low
to moderate resistance to ﬂuoroquinolones [ciproﬂoxacin MIC
up to 2 mg/l in E. coli transconjugants (Robicsek et al., 2006;
Flach et al., 2013)]. Given the data presented here, it is possible
that the presence of qnr genes in aquatic bacterial comminutes
constitutes a better marker of ﬂuoroquinolone exposure than
chromosomal mutations. Or, there could be other mutations,
outside the QRDR sequenced in this study, better suited as
markers of exposure. Culturing-based methods will be required
to fully elucidate the genetic mechanisms for how bacteria have
adapted to survive the high concentrations of ﬂuoroquinolones
here.
A contributing factor to the high abundance of ﬂuoro-
quinolone resistance mutations in the environment could be
that there is little to no cost for the bacterium to carry these
mutations. It has previously been shown that the substitutions
S83L and D87N in GyrA and S80I in ParC occurring alone, or
all three in the same organism, do not signiﬁcantly alter the
ﬁtness of E. coli in vitro, nor do the pair of S83L in GyrA and
S80I in ParC (Marcusson et al., 2009; Machuca et al., 2014).
The pair S83L and D87N in GyrA has been shown to confer a
ﬁtness cost (measured relative ﬁtness 0.97) when introduced in
E. coli K-12 MG1655 (Marcusson et al., 2009), while the pair
substitution was associated with a ﬁtness gain in E. coli ATCC
25922 (relative ﬁtness 1.14) (Machuca et al., 2014). In contrast,
the pair of D87N in GyrA together with S80I in ParC introduce
a slight ﬁtness gain (measured relative ﬁtness 1.02). Competition
experiments with wild type gyrA in E. coli and mutants encoding
either the S83L or the D87N substitution have shown that a
ciproﬂoxacin concentration of 0.1 and 2.5 µg/l, respectively, is
suﬃcient for the mutants to have a selective advantage (Gullberg
et al., 2011). Furthermore, competitive in vivo studies of other
species – i.e., Neisseria gonorrhoeae in mice (Kunz et al., 2012)
and Campylobacter jejuni in chickens (Luo et al., 2005) – have
even found a ﬁtness beneﬁt associated with gyrA mutations
corresponding to codon 83 in E. coli. In summary, a lack of
ﬁtness cost for these substitutions in the sampled environments
could explain why they appear to be very common even in
environments without any detectable ﬂuoroquinolone pollutants
or any known history thereof. As we do not yet understand the
possible advantages these genotypes may have in the absence
of ﬂuoroquinolones, and because of the limited number and
types of environments investigated in this study, we cannot
generalize to the point of claiming that resistance mutations in
gyrA and parC are common in all environmental Escherichia
communities.
The abundance of resistance mutations in the Swedish samples
stands in contrast to the frequency of ﬂuoroquinolone-resistant
infections in Sweden. On average, the S83L substitution in GyrA
was detected in 87% of the Swedish reads, the combination
of S83L and D87N in 33%, and the S80I substitution in ParC
in 43%. In Sweden, only 11.6% of the clinical invasive E. coli
isolates tested with ciproﬂoxacin were resistant in 2013 (ECDC,
2014). This is far below the abundance of resistance mutations
detected in both the Swedish lake samples and the samples
taken near a sewage treatment plant. The large diﬀerence
between the abundance of ﬂuoroquinolone resistance mutations
in the environment and the frequency of resistant E. coli
infections in Sweden is likely due to large diﬀerences between the
pathogenic E. coli strains and the strains residing in the sampled
environments. Indeed, the genome of E. coli is known to be highly
variable (Lukjancenko et al., 2010). Furthermore, competition
experiments testing the relative ﬁtness of the resistance mutations
is typically performed under optimal growing conditions, unlike
environmental conditions. It is possible that there is a selective
advantage not linked to ﬂuoroquinolones for these mutations in
the sampled environments. Indeed, our ﬁnding of how abundant
the resistance mutations are even in unpolluted environments
suggest that the sequence deﬁned as wild-type for GyrA and
ParC, respectively, in E. coli is only one of a number of common
sequences within the species.
The method presented here proved useful to compare the
abundances of mutations occurring within a short genomic
region in an entire microbial community. Next generation
sequencing techniques provide a cost-eﬀective comprehensive
approach to study entire bacterial communities without relying
on the cultivation of individual isolates. To distinguish between
resistance mutations and inter-species variability, it is important
Frontiers in Microbiology | www.frontiersin.org 7 December 2015 | Volume 6 | Article 1355
Johnning et al. Fluoroquinolone Resistance Mutations in the Environment
to design the primers as speciﬁc for the targeted taxon as possible.
If primers are not suﬃciently speciﬁc, unwanted reads need to
be ﬁltered out by matching all reads to the target sequences
and discarding reads of low resemblance. However, setting a
similarity threshold for such a ﬁltering where you allow for within
species variability is not straight-forward. Here, we chose the
threshold based on sequence alignments of diﬀerent Escherichia
and Shigella sequences and closely related genera. Additionally,
we propose that amplicon sequencing could also be used to study
resistance mutations in the ribosomal rRNA 23S gene that confer
resistance to macrolides, lincosamides, and streptogramin B
(Vester and Douthwaite, 2001). For future work in ﬁnding more
suitable markers of ﬂuoroquinolone exposure, we propose a more
controlled experimental set up where diﬀerent environments are
dosed with various concentrations of ﬂuoroquinolones for an
extended period of time and the eﬀect of the microbiota is studied
using metagenomic sequencing.
In this study, we show that there is a signiﬁcant abundance
of ﬂuoroquinolone resistance mutations in environmental
Escherichia communities residing both in ﬂuoroquinolone-
polluted and pristine environments. This suggests that the
mutations are not associated with a substantial ﬁtness cost for
the bacterium, even where there is no selective pressure for
ﬂuoroquinolone resistance. Regardless of whether the detected
mutations are suﬃcient to provide clinically relevant resistance
to ﬂuoroquinolones, they are one or two mutations closer to
obtaining a high level of resistance.
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